Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xianglian Waixi Ye is a Traditional Chinese Medicine (TCM) topical solution primarily indicated for the treatment of gynecological infections, such as vulvovaginitis and pruritus vulvae, particularly those associated with "damp-heat" patterns. The formulation is based on the synergistic herbal pair of *Saussurea costus* (Muxiang) and *Coptis chinensis* (Huanglian), which are combined with other medicinal herbs including *Sophora flavescens* (Kushen), *Cnidium monnieri* (Shechuangzi), *Kochia scoparia* (Difuzi), and *Artemisia argyi* (Aiye). These botanical extracts provide broad-spectrum antimicrobial, antifungal, and anti-inflammatory properties, targeting common pathogens like *Candida albicans* and *Trichomonas vaginalis*. It is typically administered as an external wash or sitz bath to alleviate local irritation, redness, and abnormal discharge.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xianglian Waixi Ye.